Genotype in the diagnosis of 21-hydroxylase deficiency Who should undergo CYP21A2 analysis?: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    11 August 2022

    • curprev 23:4123:41, 11 August 2022‎ 187.21.138.9 talk‎ 532 bytes +532‎ Created page with "== Target Article == Genotype in the diagnosis of 21-hydroxylase deficiency Who should undergo CYP21A2 analysis?; P Cavarzere, M Vincenzi, F Teofoli, Gaudinoae; 2013; doi_citing_unknown == Retraction == Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Hulya Gonuz; 06/01/2000 ; https://doi.org/0.1515/JPEM.2000.13.6.6..."
Retrieved from "https://wikicitingretracted.org/index.php?title=Genotype_in_the_diagnosis_of_21-hydroxylase_deficiency_Who_should_undergo_CYP21A2_analysis%3F"